Tyers Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $545K | Sell |
5,566
-374
| -6% | -$36.6K | 0.02% | 450 |
|
|
2019
Q2 | $778K | Sell |
5,940
-2,024
| -25% | -$265K | 0.03% | 379 |
|
|
2019
Q1 | $1.08M | Buy |
7,964
+1,958
| +33% | +$265K | 0.04% | 301 |
|
|
2018
Q4 | $585K | Sell |
6,006
-110
| -2% | -$10.7K | 0.02% | 374 |
|
|
2018
Q3 | $850K | Buy |
6,116
+66
| +1% | +$9.17K | 0.03% | 330 |
|
|
2018
Q2 | $751K | Buy |
6,050
+814
| +16% | +$101K | 0.03% | 345 |
|
|
2018
Q1 | $584K | Sell |
5,236
-220
| -4% | -$24.5K | 0.02% | 380 |
|
|
2017
Q4 | $653K | Buy |
5,456
+1,518
| +39% | +$182K | 0.02% | 368 |
|
|
2017
Q3 | $552K | Sell |
3,938
-704
| -15% | -$98.7K | 0.02% | 379 |
|
|
2017
Q2 | $565K | Buy |
4,642
+374
| +9% | +$45.5K | 0.02% | 377 |
|
|
2017
Q1 | $517K | Buy |
4,268
+660
| +18% | +$79.9K | 0.02% | 384 |
|
|
2016
Q4 | $441K | Buy |
+3,608
| New | +$441K | 0.02% | 374 |
|